News / 

U.S. awards flu vaccine contract

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WASHINGTON, Nov 10, 2004 (United Press International via COMTEX) -- The U.S. Department of Health and Human Services has awarded a $41 million contract to Sanofi Aventis Inc. for flu vaccines.

Health Secretary Tommy Thompson said part of the contract was to ensure there are enough eggs on hand at any time of year to manufacture flu vaccines in the event of a pandemic or future vaccine shortages.

This plan secures the egg supply for influenza vaccine manufacturing by adding more U.S. egg suppliers to the supply chain as backup suppliers and insuring the integrity of the egg supply with contingency flocks in the event avian diseases, including avian influenza, natural disasters or bioterrorism threats occur.

The contract, announced Tuesday, is nearly $10 million for the base contract to develop and implement the egg supply plan for transition to a year round egg supply, to stockpile other vaccine manufacturing supplies, and to obtain initial investigational lots of pandemic influenza vaccine.

Maintenance of the egg supply plan, which will provide an increased surge capacity for vaccine manufacturing through 2008 may increase the overall contract value to $41 million.

Copyright 2004 by United Press International.


Catch up on the top news and features from, sent weekly.
By subscribing, you acknowledge and agree to's Terms of Use and Privacy Policy.

KSL Weather Forecast